AP2877A - Materials and methods for treating viral infections with a cysteamine compound - Google Patents

Materials and methods for treating viral infections with a cysteamine compound

Info

Publication number
AP2877A
AP2877A AP2008004511A AP2008004511A AP2877A AP 2877 A AP2877 A AP 2877A AP 2008004511 A AP2008004511 A AP 2008004511A AP 2008004511 A AP2008004511 A AP 2008004511A AP 2877 A AP2877 A AP 2877A
Authority
AP
ARIPO
Prior art keywords
materials
methods
viral infections
treating viral
cysteamine compound
Prior art date
Application number
AP2008004511A
Other languages
English (en)
Other versions
AP2008004511A0 (en
Inventor
Hao Yi Liang
Francis Chi
Qingfu Xu
Original Assignee
Omega Biopharma Hk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Omega Biopharma Hk Ltd filed Critical Omega Biopharma Hk Ltd
Publication of AP2008004511A0 publication Critical patent/AP2008004511A0/xx
Application granted granted Critical
Publication of AP2877A publication Critical patent/AP2877A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
AP2008004511A 2005-11-28 2006-11-28 Materials and methods for treating viral infections with a cysteamine compound AP2877A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US74058405P 2005-11-28 2005-11-28
US81077306P 2006-06-02 2006-06-02
US81888506P 2006-07-06 2006-07-06
US84702006P 2006-09-25 2006-09-25
PCT/US2006/045652 WO2007062272A1 (en) 2005-11-28 2006-11-28 Materials and methods for treating viral infections with a cysteamine compound

Publications (2)

Publication Number Publication Date
AP2008004511A0 AP2008004511A0 (en) 2008-06-30
AP2877A true AP2877A (en) 2014-03-31

Family

ID=37769370

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2008004511A AP2877A (en) 2005-11-28 2006-11-28 Materials and methods for treating viral infections with a cysteamine compound

Country Status (21)

Country Link
US (2) US8415398B2 (de)
EP (1) EP1954258B8 (de)
JP (1) JP5138603B2 (de)
KR (1) KR101440629B1 (de)
CN (1) CN102038667A (de)
AP (1) AP2877A (de)
AR (1) AR057623A1 (de)
AU (1) AU2006318355B2 (de)
BR (1) BRPI0619377A2 (de)
CA (1) CA2631241C (de)
DK (1) DK1954258T3 (de)
ES (1) ES2392976T3 (de)
HK (1) HK1123726A1 (de)
IL (1) IL191705A (de)
MX (1) MX2008006851A (de)
MY (1) MY141003A (de)
NZ (1) NZ568464A (de)
PL (1) PL1954258T3 (de)
PT (1) PT1954258E (de)
TW (1) TWI401079B (de)
WO (1) WO2007062272A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005067899A2 (en) * 2004-01-13 2005-07-28 Omega Bio-Pharma (I.P.2) Limited Methods for treating stress and affecting biological immune systems using a cysteamine compound
AR057623A1 (es) * 2005-11-28 2007-12-05 Omega Bio Pharma H K Ltd Materiales y metodos para el tratamiento de las infecciones virales
PL2535044T3 (pl) 2006-01-27 2020-06-29 The Regents Of The University Of California Powlekane dojelitowo dwuwinian cysteaminy i cystamina
US20100151042A1 (en) * 2007-05-25 2010-06-17 Hao Yi Liang Materials and Methods for Treating Influenza Infections
WO2009129305A2 (en) 2008-04-15 2009-10-22 Tsrl, Inc. Prodrugs of neuraminidase inhibitors
GB0905451D0 (en) * 2009-03-31 2009-05-13 Novabiotics Ltd Biofilms
WO2010138419A2 (en) * 2009-05-23 2010-12-02 Obio Pharmaceutical (H.K.) Ltd. Materials and methods for treating viral infections
WO2011094693A1 (en) * 2010-02-01 2011-08-04 Mount Sinai School Of Medicine Interferon-inducing compounds and uses thereof
MX2012011938A (es) * 2010-04-15 2013-01-28 Biota Scient Management Compuesto para tratamiento de condicion o enfermedad respiratoria.
GB201021186D0 (en) 2010-12-14 2011-01-26 Novabiotics Ltd Composition
US8492386B2 (en) 2011-10-21 2013-07-23 Abbvie Inc. Methods for treating HCV
US8466159B2 (en) 2011-10-21 2013-06-18 Abbvie Inc. Methods for treating HCV
PT107925A (pt) 2011-10-21 2014-12-03 Abbvie Inc Tratamento de combinação de daa (eg. com abt-072 ou abt-333) para utilização no tratamento de hcv
ES2529143B1 (es) 2011-10-21 2015-10-26 Abbvie Inc. Combinación de al menos dos agentes antivirales de acción directa, ribavirina pero no interferón para uso de tratamiento del vhc
TWI649100B (zh) 2013-06-17 2019-02-01 地平線罕見醫學製藥有限責任公司 延遲釋放型半胱胺珠粒調配物，以及其製備及使用方法
CA2923075C (en) 2013-09-12 2022-07-26 Alios Biopharma, Inc. Aza-pyridone compounds and uses thereof
AU2016229147C1 (en) 2015-03-11 2021-03-25 Janssen Biopharma, Inc. Aza-pyridone compounds and uses thereof
US10143665B2 (en) 2015-11-17 2018-12-04 Horizon Orphan Llc Methods for storing cysteamine formulations and related methods of treatment
KR102414503B1 (ko) 2016-03-17 2022-06-29 티오제네시스 테라퓨틱스, 인크. 시스테아민의 조절 방출을 위한 조성물 및 시스테아민 민감성 장애의 전신 치료
CN109689063A (zh) 2016-04-28 2019-04-26 埃默里大学 含有炔烃的核苷酸和核苷治疗组合物及其相关用途
GB201609940D0 (en) 2016-06-07 2016-07-20 Novabiotics Ltd Microparticles
US10905660B2 (en) * 2016-06-07 2021-02-02 Novabiotics Limited Microparticles
AU2017376922B2 (en) 2016-12-15 2022-12-01 Société des Produits Nestlé S.A. Compositions and methods that modulate phosphorus or enzymes in a companion animal
WO2019060634A1 (en) 2017-09-20 2019-03-28 Thiogenesis Therapeutics, Inc. METHODS OF TREATING CYSTEAMINE SENSITIVE DISORDERS
WO2021202650A1 (en) * 2020-04-01 2021-10-07 Thiogenesis Therapeutics, Inc. Cysteamine precursor compounds for the treatment of betacoronavirus infections
CA3176642A1 (en) * 2020-05-13 2021-11-18 Regents Of The University Of Michigan Cysteamine for the treatment of sars-cov-2 infection
IL298267A (en) * 2020-05-25 2023-01-01 Novabiotics Ltd Antiviral treatment
WO2022040045A1 (en) * 2020-08-18 2022-02-24 New Amsterdam Sciences, Inc. Sod mimetic and methods of using same for the treatment of covid-19
WO2023107996A1 (en) * 2021-12-07 2023-06-15 Cila Therapeutic Inc. Anti-viral therapeutic agents and uses thereof
WO2024009307A1 (en) * 2022-07-06 2024-01-11 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Viroporins blockers/inhibitors as anti-flaviviruses agents

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5554655A (en) * 1991-09-30 1996-09-10 Jess G. Thoene Method of treating HIV infection
DE19817511A1 (de) * 1998-04-20 1999-10-21 Werner Slenczka Antivirale Wirksamkeit der Pantothensäure, des Dexpanthenols und ihrer Derivate. Hemmwirkung auf die Virusreplikation umhüllter Viren durch Blockade des Fusionsvorgangs.

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3152180A (en) 1960-08-25 1964-10-06 Studiengesellschaft Kohle Mbh Process for the production of nu-tert-alkyl amides and, if desired, nu-tert. alkyl amines
US3352912A (en) 1963-07-24 1967-11-14 Du Pont Adamantanes and tricyclo[4. 3. 1. 1 3.8] undecanes
US3538160A (en) 1965-03-24 1970-11-03 Smithkline Corp Pentacyclooctaneamines
US3483254A (en) 1967-01-03 1969-12-09 Merck & Co Inc 2-bornanemethylamines
US3496228A (en) 1967-02-16 1970-02-17 Smithkline Corp Aminotricyclononanes and the salts thereof
US3534084A (en) 1968-10-16 1970-10-13 Squibb & Sons Inc Adamantylamino-naphthyloxypropanols and related compounds
US3592934A (en) 1969-06-20 1971-07-13 Du Pont Pharmaceutical compositions and methods of controlling influenza a virus infection utilizing substituted adamantanes and tricyclo(4.3.1.13.8) undecanes
IT1055560B (it) * 1974-05-02 1982-01-11 Istituto Chemioterapico Derivati pirimidinici e relative composizioni per il trattamento di infezioni virali
US5576351A (en) * 1989-12-29 1996-11-19 Mcgaw, Inc. Use of arginine as an immunostimulator
US5292773A (en) * 1990-02-14 1994-03-08 Hirsch Gerald P Treating aids and HIV infection with methionine
ES2027527A6 (es) 1990-12-17 1992-06-01 Andromaco Lab Procedimiento para la obtencion de polimeros dotados de actividad antiviral.
DE4103177A1 (de) 1991-02-02 1992-08-06 Boehringer Mannheim Gmbh Thiazolo-(2,3-a)isoindol-derivate und diese enthaltende arzneimittel
US5314917A (en) * 1991-03-22 1994-05-24 E. B. Michaels Research Associates, Inc. Method for inactivating enveloped viruses and sperm
PT100914A (pt) * 1991-09-30 1993-10-29 Jess G Thoene Uso de compostos capazes de sofrer uma permuta mista com dissulfureto, com uma ligacao dissulfureto, no tratamento de infeccao por hiv
US5686436A (en) * 1993-05-13 1997-11-11 Hiv Diagnostics, Inc. Multi-faceted method to repress reproduction of latent viruses in humans and animals
US5725870A (en) * 1993-10-15 1998-03-10 Thoene; Jess G. Methods, composites and articles for contraception
EP0789565A4 (de) * 1993-10-15 1999-03-24 Jess G Thoene Prävention der hiv-infektion
US5714519A (en) 1995-06-07 1998-02-03 Ergo Science Incorporated Method for regulating glucose metabolism
US5684024A (en) 1996-01-25 1997-11-04 Viropharma Incorporated Pyrazole dimers compositions and methods for treating influenza
US5821243A (en) 1996-07-22 1998-10-13 Viropharma Incorporated Compounds compositions and methods for treating influenza
WO1999049860A1 (en) * 1998-03-30 1999-10-07 The Endowment For Research In Human Biology, Inc. Agents and methods for modulation of zinc transfer by metallothionein
US6063383A (en) * 1999-01-28 2000-05-16 Hsu; Wu-Ching Pharmaceutical suppository composites for fever and influenza and method of producing the composites
US6468522B1 (en) 1999-07-22 2002-10-22 University Of Medicine And Dentistry Of New Jersey Controlled release of thioamide moiety-containing therapeutic agents
US6521266B1 (en) 1999-09-23 2003-02-18 Morris A. Mann Composition for growth hormone production and release, appetite suppression, and methods related thereto
RU2175230C1 (ru) 2001-01-23 2001-10-27 Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин" Фармацевтическая композиция с противовирусной активностью и способ ее получения
DE60212365T2 (de) * 2001-04-25 2007-05-31 Cobalz Ltd., Chester Medizinische zusammensetzungen zur behandlung oder vorbeugung eines funktionellen vitamin b12 mangels
GB2377874B (en) * 2001-07-23 2005-06-22 Walcom Bio Chemicals Ind Ltd Poultry feed and the use thereof
AU2003249543A1 (en) * 2002-07-11 2004-02-02 Immune Network Ltd. Sulphydryl compounds in combination with sulphone or sulphnamide conpounds for use in microbial inflammatory diseases
US8017651B2 (en) * 2002-11-22 2011-09-13 Bionexus, Ltd. Compositions and methods for the treatment of HIV-associated fat maldistribution and hyperlipidemia
AU2003900064A0 (en) * 2003-01-09 2003-01-23 Penam Investments Pty. Ltd. A method of treatment or prophylaxis of viral infection.
GB2398497A (en) * 2003-02-19 2004-08-25 Walcom Animal Science Composition for improving immunity of animals
US20040191295A1 (en) * 2003-03-28 2004-09-30 Locniskar Mary Frances Composition and method for viral inhibition
DE10340845A1 (de) * 2003-09-04 2005-03-31 Flavin-Koenig, Dana F., Dr. Pharmazeutisches Kombinationspräparat, enthaltend Glycyrrhizinsäure, Zink und eine Verbindung, die eine Thiolgruppe oder eine zu dieser metabolisierbare Gruppe enthält
AR057623A1 (es) * 2005-11-28 2007-12-05 Omega Bio Pharma H K Ltd Materiales y metodos para el tratamiento de las infecciones virales

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5554655A (en) * 1991-09-30 1996-09-10 Jess G. Thoene Method of treating HIV infection
DE19817511A1 (de) * 1998-04-20 1999-10-21 Werner Slenczka Antivirale Wirksamkeit der Pantothensäure, des Dexpanthenols und ihrer Derivate. Hemmwirkung auf die Virusreplikation umhüllter Viren durch Blockade des Fusionsvorgangs.

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ANDERSON ROBERT, A JR et al *
BERGAMINI,A et al *

Also Published As

Publication number Publication date
MX2008006851A (es) 2008-10-09
TWI401079B (zh) 2013-07-11
IL191705A0 (en) 2009-02-11
BRPI0619377A2 (pt) 2011-09-27
KR20080077658A (ko) 2008-08-25
EP1954258B1 (de) 2012-09-05
US20130338113A1 (en) 2013-12-19
JP5138603B2 (ja) 2013-02-06
IL191705A (en) 2013-11-28
KR101440629B1 (ko) 2014-09-15
US20070135525A1 (en) 2007-06-14
CA2631241C (en) 2014-02-11
EP1954258B8 (de) 2012-10-10
WO2007062272A1 (en) 2007-05-31
US8415398B2 (en) 2013-04-09
CA2631241A1 (en) 2007-05-31
PL1954258T3 (pl) 2013-01-31
US9283198B2 (en) 2016-03-15
AR057623A1 (es) 2007-12-05
DK1954258T3 (da) 2012-10-15
HK1123726A1 (en) 2009-06-26
CN102038667A (zh) 2011-05-04
TW200733953A (en) 2007-09-16
NZ568464A (en) 2010-09-30
PT1954258E (pt) 2012-10-22
AP2008004511A0 (en) 2008-06-30
AU2006318355B2 (en) 2012-01-12
MY141003A (en) 2010-02-12
ES2392976T3 (es) 2012-12-17
EP1954258A1 (de) 2008-08-13
JP2009517395A (ja) 2009-04-30
AU2006318355A1 (en) 2007-05-31

Similar Documents

Publication Publication Date Title
AP2877A (en) Materials and methods for treating viral infections with a cysteamine compound
AP2007004128A0 (en) Tricyclic-nucleoside compounds for treating viral infections
EP2034948A4 (de) Faserverstärkte komposite und herstellungsvefahren dafür
IL222922A (en) Antibodies against neurophilin-1 and their use
PL1961744T3 (pl) Związek zawierający grupę zasadową oraz jego zastosowanie
EP1899994A4 (de) Weichmagnetische verbundmaterialien
GB2429966B (en) Shaft-ring gripper
EP1899230A4 (de) Handhabung von komprimierbaren materialien
GB0608938D0 (en) Particulate material
EP1841581A4 (de) Verbundwerkstoffe und verfahren zu deren herstellung und verwendung
ZA200805191B (en) Materials and methods for treating viral infections with a cysteamine compound
GB0607000D0 (en) Handling jitter
EP1737676A4 (de) Verfahren zur verhinderung von randaushärtung
EP1862490A4 (de) Carbodiimid-verbindungen und ihre verwendungen
GB0516245D0 (en) Process, composition and compound
HK1109939A1 (en) Techniques for handling lock-related inconsistencies
EP1909789A4 (de) Antidiabetische oxazolidindione und thiazolidindione
EP1907381A4 (de) Antidiabetische oxazolidindione und thiazolidindione
GB0518494D0 (en) Thiazole compounds
GB2418909B (en) Material handling
GB2432359B (en) Closure
IL186059A0 (en) Carbapenem derivatives and processes for the preparation thereof
GB0511532D0 (en) Particulate materials
GB0523637D0 (en) Process and compounds
EP1874347A4 (de) Zusammensetzung und verfahren zur vermeidung oder behandlung einer virusinfektion